Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450911) titled 'A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: ReValve Solutions Inc.

Condition: Mitral Regurgitation

Intervention: Device: ReValve System

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: January 27, 2026

Target Sample Size: 20

Countries of Recruitment: Georgia

To know more, visit https://clinicaltrials.gov/study/NCT07450911

Published by HT Di...